Premaitha Health PLC (LON:NIPT – Get Free Report)’s share price traded up 2.2% during mid-day trading on Wednesday . The stock traded as high as GBX 9.10 ($0.11) and last traded at GBX 9.10 ($0.11). 1,571,557 shares were traded during mid-day trading, an increase of 17% from the average session volume of 1,348,942 shares. The stock had previously closed at GBX 8.90 ($0.11).
Premaitha Health Price Performance
The stock’s 50-day moving average is GBX 9.10 and its 200 day moving average is GBX 9.10.
Premaitha Health Company Profile
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.
Featured Articles
- Five stocks we like better than Premaitha Health
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Using the MarketBeat Dividend Yield Calculator
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What Investors Need to Know About Upcoming IPOs
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Premaitha Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premaitha Health and related companies with MarketBeat.com's FREE daily email newsletter.